| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | United States | 4 | |
| #3 | Australia | 2 | |
| #4 | Canada | 2 | |
| #5 | Singapore | 2 | |
| #6 | Brazil | 1 | |
| #7 | China | 1 | |
| #8 | EPO (European Patent Office) | 1 | |
| #9 | Israel | 1 | |
| #10 | Republic of Korea | 1 | |
| #11 | Mexico | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Lydeard John | 18 |
| #2 | Bolen Joseph | 15 |
| #3 | Radovic-Moreno Aleksandar Filip | 9 |
| #4 | Radovic-Moreno Aleksandar | 5 |
| #5 | Luo Chong | 2 |
| #6 | Joseph Bolen | 2 |
| #7 | John Lydeard | 2 |
| #8 | Lin Michelle | 2 |
| #9 | Aleksandar Filip Radovic-Moreno | 1 |
| #10 | Mishra Bibhu Prasad | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021041977A1 | Compositions and methods for cd123 modification | |
| WO2021041971A1 | Compositions and methods for cll1 modification | |
| WO2020237217A1 | Compositions and methods for cd33 modification | |
| AU2019333104A1 | Genetically engineered hematopoietic stem cells and uses thereof | |
| AU2018229351A1 | Compositions and methods for inhibition of lineage specific proteins |